Tandem Diabetes Care Switzerland is a MedTech startup that focuses on the development of Sigi™, a diabetes patch pump for closed loops that works with readily available pre-filled insulin cartridges. The company, a subsidiary of Tandem Diabetes Care, Inc., is based in EPFL’s Innovation Park in Lausanne, Switzerland. Tandem Diabetes Care, Inc., the global parent company, is a notable player in the insulin delivery and diabetes technology sector, with its headquarters in San Diego, California. Established in 2014, the company operates in the Manufacturing and Medical Devices industries and has recently secured a significant Fr.8.00M Corporate Round investment on 01 September 2022, with Tandem Diabetes Care as the investor. This strategic investment highlights the confidence and support from industry leaders, which can potentially pave the way for Tandem Diabetes Care Switzerland to further revolutionize diabetes care.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Corporate Round | Fr.8.00M | 1 | 01 Sep 2022 | |
Series A | Unknown | - | 01 Nov 2021 | |
Debt Financing | Fr.500.00K | 1 | Foundation for Technological Innovation (FIT) | 08 Sep 2021 |
Non Equity Assistance | Unknown | 1 | 07 Jul 2021 | |
Seed Round | Fr.4.10M | - | 15 Dec 2020 |
No recent news or press coverage available for Tandem Diabetes Care Switzerland.